| |
| |
|
| Insider
Information: |
Giacomin Jon L |
| Relationship: |
Director |
| City: |
Dublin |
| State: |
OH |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
204,010 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,393,013 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
204,010 |
|
|
| Total
Value |
$6,393,013 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cardinal Health Inc |
CAH |
CEO, Medical Segment |
2019-08-15 |
61,387 |
|
0 |
Premium* |
|
|
Organogenesis Holdings Inc |
ORGO |
Director |
2024-02-21 |
142,623 |
2021-05-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ORGO |
Organogenesis Holdings In... |
Director |
– • – |
2024-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
51,020 |
142,623 |
0 |
- |
|
| ORGO |
Organogenesis Holdings In... |
Director |
– • – |
2023-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
65,737 |
91,603 |
0 |
- |
|
| ORGO |
Organogenesis Holdings In... |
Director |
– • – |
2022-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
20,547 |
25,866 |
0 |
- |
|
| ORGO |
Organogenesis Holdings In... |
Director |
– • – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
5,319 |
5,319 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Medical Segment |
• – – |
2019-08-15 |
4 |
D |
$42.41 |
$290,678 |
D/D |
(6,854) |
61,387 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Medical Segment |
• – – |
2019-02-15 |
4 |
D |
$55.50 |
$244,811 |
D/D |
(4,411) |
68,241 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Medical Segment |
• – – |
2018-08-20 |
4 |
S |
$51.95 |
$150,136 |
D/D |
(2,890) |
72,652 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Medical Segment |
• – – |
2018-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
23,881 |
78,929 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Medical Segment |
• – – |
2018-08-15 |
4 |
D |
$50.17 |
$169,926 |
D/D |
(3,387) |
75,542 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Medical Segment |
• – – |
2018-02-20 |
4 |
S |
$68.65 |
$549,924 |
D/D |
(7,995) |
55,048 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Medical Segment |
• – – |
2018-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
14,684 |
63,043 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2017-09-15 |
4 |
D |
$67.46 |
$57,004 |
D/D |
(845) |
48,359 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2017-08-15 |
4 |
D |
$66.76 |
$550,303 |
D/D |
(8,243) |
49,204 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2017-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
14,301 |
57,447 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2017-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
10,976 |
43,146 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2017-05-12 |
4 |
S |
$72.87 |
$1,695,685 |
D/D |
(23,270) |
32,170 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2017-05-12 |
4 |
OE |
$41.60 |
$968,032 |
D/D |
23,270 |
55,440 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2016-09-15 |
4 |
D |
$75.26 |
$63,595 |
D/D |
(845) |
32,170 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2016-08-16 |
4 |
S |
$82.77 |
$3,910,965 |
D/D |
(47,251) |
33,015 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2016-08-16 |
4 |
OE |
$27.29 |
$1,119,128 |
D/D |
39,681 |
80,266 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2016-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
11,420 |
44,598 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2016-08-15 |
4 |
D |
$83.60 |
$335,487 |
D/D |
(4,013) |
40,585 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2016-08-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,878 |
33,178 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2015-09-15 |
4 |
D |
$84.31 |
$71,158 |
D/D |
(844) |
26,300 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2015-08-15 |
4 |
D |
$84.27 |
$312,389 |
D/D |
(3,707) |
27,144 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
